Sectoral Asset Management INC Decreased Pfizer INC (PFE) Stake by $3.15 Million; Shares Declined

May 3, 2018 - By Gregory Tomko

Pfizer Inc. (NYSE:PFE) Corporate LogoDuring 2017 Q4 the big money sentiment increased to 1.06. That’s change of 0.10, from 2017Q3’s 0.96. 51 investors sold all, 675 reduced holdings as PFE ratio improved. 632 grew stakes while 134 funds took stakes. Funds hold 4.07 billion shares thus 0.28% more from 2017Q3’s 4.06 billion shares. Chickasaw Cap Management has 0.01% invested in Pfizer Inc. (NYSE:PFE) for 6,675 shs. Intrust Bancorporation Na reported 67,158 shs. Rothschild Asset invested 0.84% in Pfizer Inc. (NYSE:PFE). Tctc Limited holds 1.98% of its capital in Pfizer Inc. (NYSE:PFE) for 1.04M shs. Summit Securities Group Limited Company holds 0.08% of its capital in Pfizer Inc. (NYSE:PFE) for 17,700 shs. Winch Advisory Ltd Liability Co has invested 0.92% in Pfizer Inc. (NYSE:PFE). Huntington Bancshares reported 1.12% of its capital in Pfizer Inc. (NYSE:PFE). Jefferies Gp Lc has 0.03% invested in Pfizer Inc. (NYSE:PFE). Teacher Retirement Of Texas stated it has 4.37M shs. Guggenheim Capital Ltd Liability holds 3.26 million shs. Healthinvest Ptnrs holds 5.74% or 75,100 shs in its capital. Pettee Invsts Inc holds 3.24% or 147,623 shs. Moreover, Ionic Cap Management has 0.02% invested in Pfizer Inc. (NYSE:PFE) for 12,600 shs. Opus Investment Management has invested 1.16% in Pfizer Inc. (NYSE:PFE). Strs Ohio has invested 0.57% in Pfizer Inc. (NYSE:PFE).

PFE had 12 selling transactions and 0 insider purchases since December 15, 2017. This’s net activity of $12.99 million. JOHNSON RADY A had sold 27,323 shs worth $998,666 on Tuesday, March 13. LANKLER DOUGLAS M sold $1.84 million worth of stock or 50,000 shs. Another trade for 1,758 shs valued at $64,679 was made by CORNWELL W DON on Monday, February 26. On Monday, February 26 Shares for $1.24 million were sold by SUSMAN SALLY. $501,398 worth of Pfizer Inc. (NYSE:PFE) shs were sold by Dolsten Mikael. On Friday, December 15 a trade for 6,750 shs valued at $249,750 was made by MACKENZIE ALEXANDER R.

The stake In Pfizer Inc (PFE) was reduced owned by Jerome Pfund. According to 2017Q4 Securities and Exchange form the reduction is 9.15%. By selling 87,599 shares Sectoral Asset Management Inc made the stock sank with 3.13%. At the end of 2017Q4, the 870,074 shares of the health care company held by the hedge fund run by Jerome Pfund were priced at $31.51 million, down from 957,673 at the end of the previous reported quarter. Pfizer Inc has $207.55B market cap. The stock decreased 1.44% or $0.51 during the last trading session, touching $34.89.Pfizer Inc. is uptrending after having risen 2.43% since May 3, 2017. PFE has 28.04M volume or 15.12% up from normal. PFE underperformed by 9.12% the S&P500.

Sectoral Asset Management Inc operates about $3.30B and $800.30 million US Long portfolio. Its stake in La Jolla Pharmaceutical (NASDAQ:LJPC) was upped by 252,801 shares to 854,301 shares valued at $27.49 million in 2017Q4, according to the filing. For a total of 192,450 shares it increased its holding in Exact Sciences Corp (NASDAQ:EXAS) by 74,900 shares in the quarter, and has risen its stake in Cigna Corp (NYSE:CI).

Pfizer Inc. (NYSE:PFE) Ratings Coverage

Total analysts of 9 have positions in Pfizer (NYSE:PFE) as follows: 3 rated it a “Buy”, 1 with “Sell” and 5 with “Hold”. The positive are 33%. The firm has $43 highest while $3800 is the lowest price target. The average target $40.13 is 15.02% above the last ($34.89) price. Since November 21, 2017 according to StockzIntelligence Inc Pfizer has 14 analyst reports. On Wednesday, January 31 the rating was maintained by Morgan Stanley with “Overweight”. On Tuesday, November 21 the stock has “Buy” rating by BMO Capital Markets. In Monday, February 26 report Jefferies maintained it with “Hold” rating and $39.0 target. On Wednesday, January 31 the company was maintained by Leerink Swann. On Wednesday, January 31 the firm has “Neutral” rating by Credit Suisse given. On Sunday, January 28 the firm has “Hold” rating given by SunTrust. On Thursday, April 5 the firm has “Equal-Weight” rating given by Barclays Capital. On Friday, December 15 BMO Capital Markets maintained Pfizer Inc. (NYSE:PFE) with “Buy” rating. On Wednesday, May 2 the firm has “Outperform” rating by BMO Capital Markets given. On Tuesday, January 16 the rating was maintained by Jefferies with “Hold”.

Pfizer Inc. (NYSE:PFE) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.